Cargando…
Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature
RATIONALE: Melanoma with brain metastasis is associated with a poor prognosis and high mortality rate. As patients with this condition have been excluded from most clinical trials, data on the use of anti–programmed death 1 therapy for these patients are limited. PATIENT CONCERNS: The patient was a...
Autores principales: | Song, Jin-cheng, Ding, Xiao-lei, Sun, Xiu-hua, Safi, Mohammed, Tian, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815794/ https://www.ncbi.nlm.nih.gov/pubmed/29390382 http://dx.doi.org/10.1097/MD.0000000000009278 |
Ejemplares similares
-
Immunotherapy-related pneumonitis and bacterial pneumonia after the successful treatment of metastatic malignant melanoma with pembrolizumab: A case report
por: Ma, Qin, et al.
Publicado: (2021) -
Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report
por: Abdou, Yara, et al.
Publicado: (2019) -
A long-term survivor with esophageal melanoma and pulmonary metastasis after single-stage esophagectomy and lobectomy: Case report and literature review
por: Zhao, Tian, et al.
Publicado: (2017) -
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol
por: Hirai, Ikuko, et al.
Publicado: (2021) -
A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)